Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RUBY | AZN | AMGN | GILD | BMY |
| Company | Rubius Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0555 | 190.88 | 355.66 | 136.85 | 59.61 |
| High | 0.0570 | 192.97 | 355.66 | 137.47 | 59.69 |
| Low | 0.0550 | 187.95 | 347.80 | 134.10 | 58.37 |
| Latest | 0.0570 | 188.42 | 348.77 | 134.25 | 58.54 |
| Change | +0.0015 | +5.02 | -4.39 | -2.63 | -0.89 |
| % Change | +2.70% | +2.74% | -1.24% | -1.92% | -1.50% |
| Volume | 755,800 | 2,762,900 | 2,274,800 | 5,647,100 | 7,909,200 |
| 20-Day Average Volume | 190,760 | 1,885,910 | 2,660,480 | 6,326,585 | 13,869,300 |
| Previous Close | 0.0555 | 183.40 | 353.16 | 136.88 | 59.43 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0272 | 191.87 | 363.69 | 143.03 | 59.57 |
| 20-Day Raw Stochastic | 100.00% | 25.22% | 8.24% | 0.90% | 32.47% |
| 20-Day Relative Strength | 84.64 | 46.01 | 43.14 | 39.01 | 49.19 |
| Weighted Alpha | -42.49 | +28.71 | +17.01 | +21.27 | +8.67 |
| Today's Opinion | 88% Buy | 40% Buy | 56% Buy | 40% Buy | 56% Buy |
| Previous Opinion | 88% Buy | 24% Buy | 56% Buy | 56% Buy | 72% Buy |
| Last Month's Opinion | 24% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +185.00% since 12/21/23 | +2.63% since 03/20/26 | +0.28% since 03/20/26 | -2.16% since 03/20/26 | +1.84% since 03/20/26 |
| Low | 0.0200 on 12/22/23 | 182.39 on 03/24/26 | 345.80 on 03/24/26 | 134.10 on 03/27/26 | 56.45 on 03/24/26 |
| High | 0.0570 on 12/29/23 | 192.97 on 03/27/26 | 358.00 on 03/25/26 | 140.41 on 03/25/26 | 59.69 on 03/27/26 |
| 1-Month | |||||
| %Chg | +200.00% since 11/29/23 | -9.61% since 02/27/26 | -10.15% since 02/27/26 | -9.87% since 02/27/26 | -6.14% since 02/27/26 |
| Low | 0.0181 on 12/01/23 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 134.10 on 03/27/26 | 56.45 on 03/24/26 |
| High | 0.0570 on 12/29/23 | 206.30 on 03/02/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +251.85% since 09/29/23 | +1.41% since 12/26/25 | +4.76% since 12/26/25 | +7.66% since 12/26/25 | +7.14% since 12/26/25 |
| Low | 0.0162 on 10/09/23 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 0.0570 on 12/29/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +216.67% since 06/29/23 | +27.73% since 09/26/25 | +27.76% since 09/26/25 | +19.76% since 09/26/25 | +32.68% since 09/26/25 |
| Low | 0.0032 on 09/25/23 | 147.37 on 09/29/25 | 270.67 on 09/29/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.1150 on 09/11/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,158 | 292,222,080 | 188,010,736 | 166,634,064 | 119,523,168 |
| Shares Outstanding, K | 90,483 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -179,670,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -20,140,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.20 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 01/01/70 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.02 | 16.16 | 16.80 | 9.66 |